Switch Enhancers Interpret TGF-β and Hippo Signaling to Control Cell Fate in Human Embryonic Stem Cells

1. 30.

   NuRD Suppresses Pluripotency Gene Expression to Promote Transcriptional Heterogeneity and Lineage Commitment · 2012

39 more references, whose wording the paper’s licence keeps private.

• Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets · 2023

• YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction · 2020

• WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis · 2019

• Analysis of the role of the Hippo pathway in cancer · 2019

• Regulation of TEAD Transcription Factors in Cancer Biology · 2019

• Mechanoregulation and pathology of YAP/TAZ via Hippo and non‐Hippo mechanisms · 2018

• LncRNA UCA1 in anti-cancer drug resistance · 2017

• The Hippo pathway in tissue homeostasis and regeneration · 2017

• Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation · 2016

• LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development · 2016

• YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers · 2015

• Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion · 2014

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.